Literature DB >> 14551146

Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells.

Kris Noel Dahl1, Ranganath Parthasarathy, Connie M Westhoff, D Mark Layton, Dennis E Discher.   

Abstract

The reduction in expression of the integral membrane protein CD47 in human red blood cells (RBCs) deficient in protein 4.2 suggests that protein 4.2 may mediate a linkage of CD47 to the membrane skeleton. We compared the fractions of membrane skeleton-attached CD47, Rh-associated glycoprotein (RhAG), Rh, and band 3 in normal and protein 4.2-deficient cells using fluorescence-imaged microdeformation. We found that CD47 attachment decreases from 55% in normal cells to 25% to 35% in 4.2-deficient cells. RhAG, which has been shown to have no significant variation in expression among the cells studied, shows a significant decrease in membrane skeleton attachment in 4.2-deficient cells from 60% to 40%. Both Rh and band 3, which have also been shown to have no change in expression, show a smaller decrease from 75% attached in normal RBCs to 55% attached in 4.2-deficient cells. In normal cells, Rh phenotype influences CD47 expression but not the level of membrane skeleton attachment of CD47. In contrast, the results indicate that protein 4.2 strongly influences CD47 levels as well as the extent of membrane skeleton attachment in the RBC, whereas protein 4.2 affects membrane skeletal attachment of RhAG, Rh, and band 3 to a lesser extent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551146     DOI: 10.1182/blood-2003-04-1331

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

2.  Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

Authors:  Richard K Tsai; Pia L Rodriguez; Dennis E Discher
Journal:  Blood Cells Mol Dis       Date:  2010-03-17       Impact factor: 3.039

3.  Indentation and adhesive probing of a cell membrane with AFM: theoretical model and experiments.

Authors:  Shamik Sen; Shyamsundar Subramanian; Dennis E Discher
Journal:  Biophys J       Date:  2005-08-19       Impact factor: 4.033

4.  Species- and cell type-specific interactions between CD47 and human SIRPalpha.

Authors:  Shyamsundar Subramanian; Ranganath Parthasarathy; Shamik Sen; Eric T Boder; Dennis E Discher
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

Review 5.  The structure and function of the Rh antigen complex.

Authors:  Connie M Westhoff
Journal:  Semin Hematol       Date:  2007-01       Impact factor: 3.851

6.  Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans.

Authors:  K Srivastava; M U Bueno; W A Flegel
Journal:  Immunohematology       Date:  2022-04-29

7.  An 11-amino acid beta-hairpin loop in the cytoplasmic domain of band 3 is responsible for ankyrin binding in mouse erythrocytes.

Authors:  Marko Stefanovic; Nicholas O Markham; Erin M Parry; Lisa J Garrett-Beal; Amanda P Cline; Patrick G Gallagher; Philip S Low; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

8.  Protein 4.2 binds to the carboxyl-terminal EF-hands of erythroid alpha-spectrin in a calcium- and calmodulin-dependent manner.

Authors:  Catherine Korsgren; Luanne L Peters; Samuel E Lux
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

Review 9.  Refined views of multi-protein complexes in the erythrocyte membrane.

Authors:  T J Mankelow; T J Satchwell; N M Burton
Journal:  Blood Cells Mol Dis       Date:  2012-03-31       Impact factor: 3.039

10.  Fission yeast Cyk3p is a transglutaminase-like protein that participates in cytokinesis and cell morphogenesis.

Authors:  Luther W Pollard; Masayuki Onishi; John R Pringle; Matthew Lord
Journal:  Mol Biol Cell       Date:  2012-05-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.